ORGANOGENESIS HOLDINGS INC. Long-term Line of Credit, Noncurrent
ORGANOGENESIS HOLDINGS INC. (ORGO) had Long-term Line of Credit, Noncurrent of $0 as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLineOfCredit · last filed 2022-03-01
- 2021-12-31: Long-term Line of Credit, Noncurrent $0.00.
- 2021-09-30: Long-term Line of Credit, Noncurrent $0.00.
- 2021-06-30: Long-term Line of Credit, Noncurrent $10.00M.
- 2021-03-31: Long-term Line of Credit, Noncurrent $10.00M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $10.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $10.00M 10-K · filed 2022-03-01 |
| 2020-09-30 | $39.35M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $39.35M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $33.48M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $33.48M 10-K · filed 2021-03-16 |
| 2019-09-30 | $33.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $33.48M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $30.98M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $26.48M 10-K · filed 2020-03-09 |
| 2017-12-31 | $17.62M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |